BioNTech's stock rallies after it posts surprise Q3 profit and revenue that tops estimates
Company looks to combination vaccines, cancer treatments to drive future growth
Stay updated with breaking news from Immunizations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Company looks to combination vaccines, cancer treatments to drive future growth
BioNTech stock has dropped 36% this year as demand fell for its Covid-19 vaccines produced with Pfizer.
BioNTech stock has dropped 36% this year as demand fell for its Covid-19 vaccines produced with Pfizer.
By Helena Smolak BioNTech warned that full-year revenue from Covid-19 vaccines would be weaker than previously expected and reduced its spending plans. The...
By Ben Glickman Clinical-stage pharmaceutical company Sequoia Vaccines filed for an initial public offering with the Securities and Exchange Commission...